Keratinocytes express cytokines and nerve growth factor in response to neuropeptide activation of the ERK1/2 and JNK MAPK transcription pathways

Regulatory Peptides

Volumn 186, Issue , 2013, Pages 92-103

  Shi, Xiaoyou ^a,b   Wang, Liping ^a   Clark, J David ^a,b   Kingery, Wade S ^a  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Calcitonin gene related peptide; Cytokines; Keratinocyte; Mitogen activated protein kinases; Nerve growth factor; Substance P

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NERVE GROWTH FACTOR; NEUROPEPTIDE; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; SUBSTANCE P; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVATION; KERATINOCYTE; MEDIATOR RELEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

CALCITONIN GENE-RELATED PEPTIDE; CYTOKINES; KERATINOCYTE; MITOGEN ACTIVATED PROTEIN KINASES; NERVE GROWTH FACTOR; SUBSTANCE P;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; INDOLES; INFLAMMATION MEDIATORS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; KERATINOCYTES; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; NERVE GROWTH FACTORS; NEUROKININ-1 RECEPTOR ANTAGONISTS; PIPERIDINES; RATS; RECEPTOR ACTIVITY-MODIFYING PROTEIN 1; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE; SUBSTANCE P; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 84883521977     PISSN: 01670115     EISSN: 18731686     Source Type: Journal    
DOI: 10.1016/j.regpep.2013.08.001     Document Type: Article

References (42)

1. da Silva L., Carvalho E., Cruz M.T. Role of neuropeptides in skin inflammation and its involvement in diabetic wound healing. Expert Opin Biol Ther 2010, 10:1427-1439.
2. Roosterman D., Goerge T., Schneider S.W., Bunnett N.W., Steinhoff M. Neuronal control of skin function: the skin as a neuroimmunoendocrine organ. Physiol Rev 2006, 86:1309-1379.
3. Dallos A., Kiss M., Polyanka H., Dobozy A., Kemeny L., Husz S. Effects of the neuropeptides substance P, calcitonin gene-related peptide, vasoactive intestinal polypeptide and galanin on the production of nerve growth factor and inflammatory cytokines in cultured human keratinocytes. Neuropeptides 2006, 40:251-263.
4. Burbach G.J., Kim K.H., Zivony A.S., Kim A., Aranda J., Wright S., Naik S.M., Caughman S.W., Ansel J.C., Armstrong C.A. The neurosensory tachykinins substance P and neurokinin A directly induce keratinocyte nerve growth factor. J Invest Dermatol 2001, 117:1075-1082.
5. Shi X., Wang L., Li X., Sahbaie P., Kingery W.S., Clark J.D. Neuropeptides contribute to peripheral nociceptive sensitization by regulating interleukin-1beta production in keratinocytes. Anesth Analg 2011, 113:175-183.
6. Carvalho R.F., Nilsson G., Harvima I.T. Increased mast cell expression of PAR-2 in skin inflammatory diseases and release of IL-8 upon PAR-2 activation. Exp Dermatol 2010, 19:117-122.
7. Marinus J., Moseley G.L., Birklein F., Baron R., Maihofner C., Kingery W.S., van Hilten J.J. Clinical features and pathophysiology of complex regional pain syndrome. Lancet Neurol 2011, 10:637-648.
8. Li W.W., Guo T.Z., Li X.Q., Kingery W.S., Clark J.D. Fracture induces keratinocyte activation, proliferation, and expression of pro-nociceptive inflammatory mediators. Pain 2010, 151:843-852.
9. Clark J.D., Shi X., Li X., Qiao Y., Liang D., Angst M.S., Yeomans D.C. Morphine reduces local cytokine expression and neutrophil infiltration after incision. Mol Pain 2007, 3:28.
10. Weber M., Birklein F., Neundorfer B., Schmelz M. Facilitated neurogenic inflammation in complex regional pain syndrome. Pain 2001, 91:251-257.
11. Leis S., Weber M., Isselmann A., Schmelz M., Birklein F. Substance-P-induced protein extravasation is bilaterally increased in complex regional pain syndrome. Exp Neurol 2003, 183:197-204.
12. Sun J., Ramnath R.D., Zhi L., Tamizhselvi R., Bhatia M. Substance P enhances NF-kappaB transactivation and chemokine response in murine macrophages via ERK1/2 and p38 MAPK signaling pathways. Am J Physiol Cell Physiol 2008, 294:C1586-C1596.
13. Fiebich B.L., Schleicher S., Butcher R.D., Craig A., Lieb K. The neuropeptide substance P activates p38 mitogen-activated protein kinase resulting in IL-6 expression independently from NF-kappa B. J Immunol 2000, 165:5606-5611.
14. Tokuda M., Miyamoto R., Sakuta T., Nagaoka S., Torii M. Substance P activates p38 mitogen-activated protein kinase to promote IL-6 induction in human dental pulp fibroblasts. Connect Tissue Res 2005, 46:153-158.
15. Azzolina A., Guarneri P., Lampiasi N. Involvement of p38 and JNK MAPKs pathways in Substance P-induced production of TNF-alpha by peritoneal mast cells. Cytokine 2002, 18:72-80.
16. Okabe T., Hide M., Koro O., Yamamoto S. Substance P induces tumor necrosis factor-alpha release from human skin via mitogen-activated protein kinase. Eur J Pharmacol 2000, 398:309-315.
17. Azzolina A., Bongiovanni A., Lampiasi N. Substance P induces TNF-alpha and IL-6 production through NF kappa B in peritoneal mast cells. Biochim Biophys Acta 2003, 1643:75-83.
18. Yu X.J., Li C.Y., Xu Y.H., Chen L.M., Zhou C.L. Calcitonin gene-related peptide increases proliferation of human HaCaT keratinocytes by activation of MAP kinases. Cell Biol Int 2009, 33:1144-1148.
19. Presland R.B., Fleckman P. Tetracycline-regulated gene expression in epidermal keratinocytes. Methods Mol Biol 2005, 289:273-286.
20. Kuechle M.K., Presland R.B., Lewis S.P., Fleckman P., Dale B.A. Inducible expression of filaggrin increases keratinocyte susceptibility to apoptotic cell death. Cell Death Differ 2000, 7:566-573.
21. Haydock P.V., Blomquist C., Brumbaugh S., Dale B.A., Holbrook K.A., Fleckman P. Antisense profilaggrin RNA delays and decreases profilaggrin expression and alters in vitro differentiation of rat epidermal keratinocytes. J Invest Dermatol 1993, 101:118-126.
22. Baden H.P., Kubilus J. The growth and differentiation of cultured newborn rat keratinocytes. J Invest Dermatol 1983, 80:124-130.
23. Presland R.B., Kuechle M.K., Lewis S.P., Fleckman P., Dale B.A. Regulated expression of human filaggrin in keratinocytes results in cytoskeletal disruption, loss of cell-cell adhesion, and cell cycle arrest. Exp Cell Res 2001, 270:199-213.
24. Wang L., Zhao R., Shi X., Wei T., Halloran B.P., Clark D.J., Jacobs C.R., Kingery W.S. Substance P stimulates bone marrow stromal cell osteogenic activity, osteoclast differentiation, and resorption activity in vitro. Bone 2009, 45:309-320.
25. Gitter B.D., Bruns R.F., Howbert J.J., Waters D.C., Threlkeld P.G., Cox L.M., Nixon J.A., Lobb K.L., Mason N.R., Stengel P.W., Cockerham S.L., Silbaugh S.A., Gehlert D.R., Schober D.A., Iyengar S., Calligaro D.O., Regoli D., Hipskind P.A. Pharmacological characterization of LY303870: a novel, potent and selective nonpeptide substance P (neurokinin 1) receptor antagonist. J Pharmacol Exp Ther 1995, 275:737-744.
26. Iyengar S., Hipskind P.A., Gehlert D.R., Schober D., Lobb K.L., Nixon J.A., Helton D.R., Kallman M.J., Boucher S., Couture R., Li D.L., Simmons R.M.A. LY303870, a centrally active neurokinin-1 antagonist with a long duration of action. J Pharmacol Exp Ther 1997, 280:774-785.
27. Bae S., Matsunaga Y., Tanaka Y., Katayama I. Autocrine induction of substance P mRNA and peptide in cultured normal human keratinocytes. Biochem Biophys Res Commun 1999, 263:327-333.
28. Liu J.Y., Hu J.H., Zhu Q.G., Li F.Q., Sun H.J. Substance P receptor expression in human skin keratinocytes and fibroblasts. Br J Dermatol 2006, 155:657-662.
29. Roggenkamp D., Kopnick S., Stab F., Wenck H., Schmelz M., Neufang G. Epidermal nerve fibers modulate keratinocyte growth via neuropeptide signaling in an innervated skin model. J Invest Dermatol 2013, 133:1620-1628.
30. Hou Q., Barr T., Gee L., Vickers J., Wymer J., Borsani E., Rodella L., Getsios S., Burdo T., Eisenberg E., Guha U., Lavker R., Kessler J., Chittur S., Fiorino D., Rice F., Albrecht P. Keratinocyte expression of calcitonin gene-related peptide beta: implications for neuropathic and inflammatory pain mechanisms. Pain 2011, 152:2036-2051.
31. Takahashi K., Nakanishi S., Imamura S. Direct effects of cutaneous neuropeptides on adenylyl cyclase activity and proliferation in a keratinocyte cell line: stimulation of cyclic AMP formation by CGRP and VIP/PHM, and inhibition by NPY through G protein-coupled receptors. J Invest Dermatol 1993, 101:646-651.
32. Tanaka T., Danno K., Ikai K., Imamura S. Effects of substance P and substance K on the growth of cultured keratinocytes. J Invest Dermatol 1988, 90:399-401.
33. Honore P., Kamp E.H., Rogers S.D., Gebhart G.F., Mantyh P.W. Activation of lamina I spinal cord neurons that express the substance P receptor in visceral nociception and hyperalgesia. J Pain 2002, 3:3-11.
34. Wei T., Guo T.Z., Li W.W., Hou S., Kingery W., Clark J.D. Keratinocyte expression of inflammatory mediators plays a crucial role in substance P-induced acute and chronic pain. J Neuroinflammation 2012, 9:181.
35. Sabsovich I., Wei T., Guo T.Z., Zhao R., Shi X., Li X., Yeomans D.C., Klyukinov M., Kingery W.S., Clark J.D. Effect of anti-NGF antibodies in a rat tibia fracture model of complex regional pain syndrome type I. Pain 2008, 138:47-60.
36. Guo T.Z., Wei T., Shi X., Li W.W., Hou S., Wang L., Tsujikawa K., Rice K.C., Cheng K., Clark D.J., Kingery W.S. Neuropeptide deficient mice have attenuated nociceptive, vascular, and inflammatory changes in a tibia fracture model of complex regional pain syndrome. Mol Pain 2012, 8:85.
37. Wei T., Li W.W., Guo T.Z., Zhao R., Wang L., Clark D.J., Oaklander A.L., Schmelz M., Kingery W.S. Post-junctional facilitation of Substance P signaling in a tibia fracture rat model of complex regional pain syndrome type I. Pain 2009, 144:278-286.
38. Lee J.C., Laydon J.T., McDonnell P.C., Gallagher T.F., Kumar S., Green D., McNulty D., Blumenthal M.J., Heys J.R., Landvatter S.W., et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994, 372:739-746.
39. Muthusamy V., Piva T.J. The UV response of the skin: a review of the MAPK, NFkappaB and TNFalpha signal transduction pathways. Arch Dermatol Res 2010, 302:5-17.
40. Schett G., Zwerina J., Firestein G. The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis. Ann Rheum Dis 2008, 67:909-916.
41. Blackwell T.S., Christman J.W. The role of nuclear factor-kappa B in cytokine gene regulation. Am J Respir Cell Mol Biol 1997, 17:3-9.
42. Lappas M., Permezel M., Georgiou H.M., Rice G.E. Nuclear factor kappa B regulation of proinflammatory cytokines in human gestational tissues in vitro. Biol Reprod 2002, 67:668-673.